Background
Goudsmit, Jaap was born on July 22, 1951 in Amsterdam, The Netherlands.
Goudsmit, Jaap was born on July 22, 1951 in Amsterdam, The Netherlands.
Doctor of Medicine cum laude, University Amsterdam, 1978. Doctor of Philosophy, University Amsterdam, 1982.
Visiting fellow laboratory central nervous syst. studies National Institute Neurological and Communicative Disorders and Stroke National Institutes of Health, Bethesda, Maryland, 1978—1980, visiting fellow viral oncology and molecular pathology section National Cancer Institute, 1980, visiting scientist laboratory central nervous syst. studies National Institute Neurological and Communicative Disorders and Stroke, 1982, 1983—1984. Research associate department virology The Netherlands Organization Advancement Pure Research University Amsterdam, 1980—1982, training medical microbiologist laboratorium voor de gezondheidsleer, 1980—1983, member medical staff department virology Academy Medical Center, 1983, chief department virology Human Retrovirus Laboratory, 1986—2002, head department human retrovirology Academy Medical Center, 1995—2002, chairman Institute Research Education Academy Medical Center, 1999—2002, chairman Research Institute Infectious Diseases, Academy Medical Center, 1999—2002. Senior vice president vaccine research Crucell N.V., Leiden, Netherlands, 2001—2002, executive vice president vaccine Research and Development, chief science officer Netherlands, since 2002.
Visiting professor Aaron Diamond Acquired Immune Deficiency Syndrome Research Center New York University, New York City, 1993—1996. Consultant World Health Organization on Appropriate Human Immunodeficiency Virus Vaccines for Developing Countries, Geneva, 1993—1994. Member project management group European Vaccine Against Acquired Immune Deficiency Syndrome, since 1989.
Co-chair Euuropean Vaccine Effort Against Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, since 2000. Chairman science advisory board Rockefeller Foundation International Acquired Immune Deficiency Syndrome Vaccine Initiative, 1996. Project leader European Acquired Immune Deficiency Syndrome Virus Serosurveillance Programme, 1993—1996.
Member steering committee Preclinical Studies in Chimpanzees and Relevant Primate Models, 1992—1993, Centralized Facility Human Immunodeficiency Virus Genome Analysis, 1992—1996. Project co-leader steering committee Acquired Immune Deficiency Syndrome Foundation/Prevention Foundation, Dutch Vaccine Effort RIVM/Administrative Management College, 1992. Head steering committee World Health Organization Secondary Laboratory Netherlands World Health Organization Network Human Immunodeficiency Virus Isolation and Characterization, 1991—1998.
He chaired the Scientific Advisory Committee of the International Acquired Immune Deficiency Syndrome Vaccine Initiative (IAVI) and has been a member of its board. In 2003 he was elected as member of the Human Immunodeficiency Virus Vaccine Enterprise Product Development Working Group of the Gates Foundation and in 2006 he was affiliated with Pevion Biotech as member of the Supervisory Board.